Please login to bookmark Close
Drug company Ono Pharmaceutical has faced tough questioning by an appeals court in a fight with IP Australia over a decision that secured it a patent extension for its cancer immunotherapy drug Opdivo.
Lawyer reprimanded for failing to pay barristers’ fees in ‘silly act of desperation’
Please login to bookmark Close
A Melbourne lawyer has been found guilty of 14 charges of professional misconduct for misappropriating trust funds and failing to pay tens of thousands of dollars in fees to seven barristers.
Facial recognition software company Clearview AI breached privacy laws, regulator finds
Please login to bookmark Close
US-based facial recognition software company Clearview AI has been ordered to cease collecting facial images from individuals in Australia and destroy all the data it has collected within the country.
Epic’s evidence in clash with Apple could be first in competition case
Please login to bookmark Close
Epic Game’s plan to lead econometric evidence in its dispute with Apple could be the first time such evidence has been led in a competition case in Australia, a judge has said, as he warned that the companies’ “unlimited resources and enthusiasm for victory” should not bog the case down.
Bridge Street Capital hit with costs for funding winding-up defence of ‘woefully’ insolvent developer
Please login to bookmark Close
Corporate advisory firm Bridge Street Capital has been hit with costs for funding the defence to a winding up application for a Sydney property developer which a judge found was “woefully” insolvent.
E&P Financial to defend Dixon Advisory class action
Please login to bookmark Close
E&P Financial Group says it will defend a class action brought against it, subsidiary Dixon Advisory and director Alan Dixon, alleging they reaped millions of dollars in fees by pushing unsuitable financial products onto investors.
Class action accuses Dixon Advisory of providing conflicted financial advice
Please login to bookmark Close
Financial services company Dixon Advisory has been hit with a class action for allegedly pushing financial products onto investors that it stood to reap hundreds of millions of dollars in fees from and failing to disclose its alleged conflict of interest.
Judge slams indictment in cartel case as ‘complete shemozzle’
Please login to bookmark Close
A judge has declined to quash the indictment in a high-profile criminal case over a $2.5 billion ANZ share placement but sent prosecutors back to the drawing board to remedy its defects, calling the state of affairs “a complete shemozzle”.
JPMorgan GC sat in on ACCC interviews despite involvement in alleged cartel, court hears
Please login to bookmark Close
JPMorgan’s general counsel for Australia and New Zealand was allowed to sit in on witness interviews during an ACCC cartel investigation into ANZ’s $2.5 billion share placement despite allegedly being involved in the cartel conduct, a judge has heard.
Court won’t block Monash Health from terminating unvaccinated nurses
Please login to bookmark Close
A court has struck down a bid by unvaccinated nurses to restrain Monash Health from terminating their employment in accordance with the Victorian COVID-19 public health directions requiring them to be vaccinated, saying their case is “at best, weak”.